Skip to main content
. 2020 Mar 28;8(3):e2662. doi: 10.1097/GOX.0000000000002662

Table 5.

Outcomes

Overall
(n = 126)
Restrictive
(n = 85)
Liberal
(n = 41)
p value AOR (95% CI)* adjusted p
Wound complications Overall 44 (34.9) 13 (15.3) 31 (75.6) < 0.001 2.62 (1.77, 8.94) < 0.001
After excluding anastomosis revisions 38 (30.1) 11 (12.9) 27 (65.9) < 0.001 1.96 (1.32, 5.43) < 0.001
Early reoperations 6 (4.8) 2 (2.5) 4 (9.8) 0.085 5.81 (0.94, 15.67) 0.071
Total flap loss 6 (4.8) 2 (2.4) 4 (9.8) 0.087 5.80 (0.90, 13.75) 0.065
Partial flap loss 26 (20.6) 6 (7.1) 20 (48.8) < 0.001 3.00 (1.70, 12.84) < 0.001
Dehiscence 10 (7.9) 3 (3.5) 7 (17.1) 0.013 5.17 (1.15, 13.32) 0.033
Infection 13 (10.3) 5 (5.9) 8 (19.5) 0.028 3.81 (1.08, 13.40) 0.037
Fat necrosis 17 (13.5) 4 (4.7) 13 (31.7) < 0.001 11.92 (2.8, 25.70) 0.001
Donor site 13 (10.3) 6 (7.1) 7 (17.1) 0.117 1.94 (0.51, 7.31) 0.328
Systemic complications 24 (19.0) 13 (15.3) 11 (26.8) 0.148 2.44 (0.90, 6.61) 0.079
Adjusted Mean Difference Adjusted p
Mean HLOS 5.3 ± 0.5 5.0 ± 0.5 7.2 ± 0.5 0.038 1.7 (0.9, 2.1) 0.015

Values are reported in n (%) unless stated otherwise.

Adjusting for anesthesia time, intra – operative blood loss, neoadjuvant radiation, intra – operative blood transfusion and use of albumin.

Donor site complications include dehiscence, infection and fat necrosis of the donor site. The rest of the outcomes are recipient site associated.

HLOS, hospital length of stay.